Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine
· Delayed Price · Currency is JOD · Price in USD 4.650
0.00 (0.00%)
At close: Mar 4, 2026
Jerusalem Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 10.23 | 5.04 | 6.96 | 7.17 | 6.6 | Upgrade
|
| Depreciation & Amortization | 2.12 | 1.6 | 1.56 | 2.22 | 2.44 | Upgrade
|
| Other Amortization | - | 0.57 | 0.55 | 0.6 | 0.6 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | -0 | -0.11 | - | -0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.57 | -0.79 | 0.15 | -0 | 0.01 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 0 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.8 | 1.83 | 0.14 | 0.63 | 0.43 | Upgrade
|
| Other Operating Activities | 2.58 | 2.48 | -0.23 | 1.97 | 1.91 | Upgrade
|
| Change in Accounts Receivable | -11.3 | -3.89 | 1.48 | -0.76 | -7.17 | Upgrade
|
| Change in Inventory | -5.13 | 1.67 | 1.3 | 3.76 | -1.01 | Upgrade
|
| Change in Accounts Payable | 1.59 | -0.24 | -2.95 | 1.12 | 0.78 | Upgrade
|
| Change in Other Net Operating Assets | 4.21 | 3.49 | 0.35 | 0.29 | 1.48 | Upgrade
|
| Operating Cash Flow | 3.54 | 11.75 | 9.2 | 17 | 6.05 | Upgrade
|
| Operating Cash Flow Growth | -69.89% | 27.79% | -45.90% | 181.03% | 217.13% | Upgrade
|
| Capital Expenditures | -2.06 | -1.81 | -1.36 | -0.68 | -2.19 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0.91 | - | 0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.03 | -0.82 | -0.59 | -0.49 | -0.11 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | -2.3 | - | - | Upgrade
|
| Investment in Securities | -3.84 | -0.52 | -3.73 | -2.58 | 0.59 | Upgrade
|
| Other Investing Activities | 0.25 | 0.29 | -0.08 | - | - | Upgrade
|
| Investing Cash Flow | -6.67 | -2.87 | -7.15 | -3.75 | -1.69 | Upgrade
|
| Long-Term Debt Issued | 0.68 | 1.86 | 1.57 | 0.14 | - | Upgrade
|
| Long-Term Debt Repaid | -1.31 | -2.76 | -1.5 | -0.62 | -1.9 | Upgrade
|
| Net Debt Issued (Repaid) | -0.63 | -0.9 | 0.07 | -0.48 | -1.9 | Upgrade
|
| Common Dividends Paid | -0.82 | -1.69 | -2.55 | -2.14 | -1.34 | Upgrade
|
| Other Financing Activities | -0.31 | -0.36 | -0.23 | -0.2 | -0.16 | Upgrade
|
| Financing Cash Flow | -1.75 | -2.95 | -2.7 | -2.82 | -3.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.12 | -0.78 | -0.49 | -8.14 | 2.51 | Upgrade
|
| Net Cash Flow | 0.23 | 5.16 | -1.14 | 2.29 | 3.48 | Upgrade
|
| Free Cash Flow | 1.48 | 9.94 | 7.84 | 16.32 | 3.86 | Upgrade
|
| Free Cash Flow Growth | -85.07% | 26.79% | -51.95% | 322.88% | 764.17% | Upgrade
|
| Free Cash Flow Margin | 2.97% | 24.96% | 19.77% | 35.37% | 8.35% | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.55 | 0.44 | 0.91 | 0.21 | Upgrade
|
| Cash Income Tax Paid | - | 0.15 | 2.01 | 0.65 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 0.4 | 8.43 | 5.08 | 12.57 | 2.48 | Upgrade
|
| Unlevered Free Cash Flow | 0.58 | 8.44 | 5.11 | 12.61 | 2.51 | Upgrade
|
| Change in Working Capital | -10.62 | 1.04 | 0.18 | 4.41 | -5.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.